The RACE for Children Act, signed by President Donald Trump earlier this month, aims to increase the number of clinical trials available to pediatric cancer patients. While there are almost 900 cancer drugs in development for adults, only a small portion of the treatments are targeted toward pediatric patients. The new law, which was backed by more than 250 advocacy organizations and received bipartisan support from federal legislators, allows for experimental drugs being tested in adults that display possible efficacy in the treatment of pediatric cancer to be used in clinical trials with children.
Children’s Hospital Colorado on Tuesday hosted a celebration of the bill’s signing. Scott Gottlieb, MD, commissioner of the Food and Drug Administration, and Colorado’s Democratic Sen. Michael Bennet, who sponsored the legislation, were among those in attendance.
Mr. Bennet described the bill as “a breakthrough for kids fighting cancer,” according to The Denver Post.
More articles on quality:
Keck Medicine of USC names 1st chief patient safety officer
American Academy of Nursing honors 5 nurses as ‘Living Legends’
26% of readmissions are medication related, study shows
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.